Medtronic, Inc. (MDT)
-NYSE 51.33 
0.13(0.25%) May 24, 4:00PM EDT|After Hours
:
51.36 0.03 (0.05%) May 24, 4:54PM EDT
| Prev Close: | 51.46 |
|---|
| Open: | 51.11 |
|---|
| Bid: | 50.21 x 200 |
|---|
| Ask: | 52.73 x 100 |
|---|
| 1y Target Est: | 55.24 |
|---|
| Beta: | 1.02 |
|---|
| Next Earnings Date: | 20-Aug-13 |
|---|
| Day's Range: | 50.77 - 51.67 |
|---|
| 52wk Range: | 35.67 - 53.83 |
|---|
| Volume: | 4,000,328 |
|---|
| Avg Vol (3m): | 4,351,100 |
|---|
| Market Cap: | 52.04B |
|---|
| P/E (ttm): | 15.18 |
|---|
| EPS (ttm): | 3.38 |
|---|
| Div & Yield: | 1.04 (2.10%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Obamacare: 3 Things You Should Knowat Motley Fool(Sat 8:35AM EDT)
- Final Glance: Medical Devices companiesAP(Fri, May 24)
- [video] Summer Investing: Advice From the Prosat CNBC(Fri, May 24)
- St. Jude Begins EnligHTNment StudyZacks(Fri, May 24)
- Midday Glance: Medical Devices companiesAP(Fri, May 24)
- Early Glance: Medical Devices companiesAP(Fri, May 24)
- Medtronic Inc. Stock Buy Recommendation Reiterated (MDT)at TheStreet(Fri, May 24)
- Medtronic CEO Omar Ishrak to Speak at Sanford Bernstein Strategic Decisions ConferenceThomson Reuters ONE(Fri, May 24)
- Dividend Growth Gem Medtronic Is A Cash Cowat Seeking Alpha(Fri, May 24)
- [$$] Big Profits From Bad Backsat Barrons.com(Thu, May 23)
- Are These Tuesday Post-Earning Movers a Buy?at Motley Fool(Thu, May 23)
- Thursday 5/23 Insider Buying Report: MDT, WDat Forbes(Thu, May 23)
- McDonald’s Initiates a Dividend, Seagate Gets An Upgrade, and 3 More Hot Stocksat Wall St. Cheat Sheet(Thu, May 23)
- Medtronic Completes Enrollment in Landmark U.S. Study of Symplicity(TM) Renal Denervation System for Treatment-Resistant HypertensionThomson Reuters ONE(Thu, May 23)
- Medtronic's In.Pact Falcon yields positive outcomes in small coronary arteriestheflyonthewall.com(Thu, May 23)
Key Statistics
| Forward P/E (1 yr): | 12.46 |
|---|
| P/S (ttm): | 3.18 |
|---|
| Ex-Dividend Date: | 03-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Apr-14)
: | 3.84 |
|---|
| Quarterly EPS Est
(Jul-13)
: | 0.88 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.93 |
|---|
Business Summary
Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It provides products to diagnose, treat, and manage heart rhythm disorders and heart failure, including implantable cardiac pacemakers, implantable cardioverter defib...
View More